Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Xencor, Inc. < Previous 1 2 Next > Xencor Regains CD20 x CD3 Bispecific T-Cell Engager June 13, 2024 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Reports First Quarter 2024 Financial Results May 09, 2024 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Appoints Bart Cornelissen as Chief Financial Officer April 09, 2024 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Present at Upcoming Investor Conferences February 28, 2024 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Reports Fourth Quarter and Full Year 2023 Financial Results February 27, 2024 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update February 20, 2024 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Xencor, Inc. Via Business Wire Tickers XNCR Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy January 02, 2024 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Reports Third Quarter 2023 Financial Results November 07, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million November 07, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting November 03, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023 October 31, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Announces Planned Retirement of Chief Financial Officer John Kuch October 26, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Present Multiple Posters at the SITC Annual Meeting September 27, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors September 19, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Reports Second Quarter 2023 Financial Results August 03, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023 July 27, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 Congress May 30, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Reports First Quarter 2023 Financial Results May 08, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023 May 01, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Appoints Nancy Valente, M.D., as Chief Development Officer April 26, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023 April 17, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Present Preclinical Data from Novel XmAb® CD28 Bispecific Antibody Programs at the American Association for Cancer Research Annual Meeting 2023 March 14, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Reports Fourth Quarter and Full Year 2022 Financial Results February 23, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023 February 16, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Present at the SVB Securities Global Biopharma Conference February 07, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates January 09, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Present at the 41st Annual J.P. Morgan Healthcare Conference January 04, 2023 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor Presents Data from Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin Lymphoma at the American Society of Hematology Annual Meeting December 12, 2022 From Xencor, Inc. Via Business Wire Tickers XNCR Xencor to Present at Upcoming Investor Conferences November 10, 2022 From Xencor, Inc. Via Business Wire Tickers XNCR < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.